Amedisys Inc

More Details of Amedisys Inc Company

Amedisys, Inc. is a healthcare services company. It provides in-home healthcare and related services to the chronic, co-morbid and aging American population. Its segments include home health, hospice and high acuity care. Its home health segment delivers a range of services in the homes of individuals who may be recovering from an illness, injury or surgery. Its nurses administer medications, care for wounds, monitor vital signs and provide a range of other nursing services. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, palliative and skilled nursing facility care to patients in their homes. It owns and operates 347 Medicare-certified home health care centers, 164 Medicare-certified hospice care centers and eight admitting high acuity care joint ventures in 38 states within the United States and the District of Columbia.

Company Info

Company codeAMED

Company nameAmedisys Inc

IPO dateAug 17, 1994

Founded at1994

CEOMr. Richard M. Ashworth

Number of employees19000

Security typeOrdinary Share

Fiscal year-endAug 17

Address3854 American Way, Suite A

CityBATON ROUGE

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited States of America

Postal code70816

Phone12252922031

Websitehttps://www.amedisys.com/

Company codeAMED

IPO dateAug 17, 1994

Founded at1994

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Scott G. Ginn

Executive Vice President, Chief Financial Officer, Chief Operating Officer

38.41K

+52.79%

Mr. Bruce D. Perkins

Independent Director

20.73K

-7.49%

Ms. Julie D. Klapstein

Lead Independent Director

12.66K

-11.70%

Mr. Nick Muscato

Chief Strategy Officer

7.02K

+229.53%

Dr. Jeffrey A. Rideout, M.D.

Independent Director

5.97K

-21.95%

Ms. Ivanetta Davis Samuels

Independent Director

4.23K

-28.39%

Mr. Adam Holton

Chief People Officer

--

Dr. Molly J. Coye, M.D.

Independent Director

--

Ms. Teresa L. Kline

Independent Director

--

Ms. Vickie L. Capps, CPA

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Scott G. Ginn

Executive Vice President, Chief Financial Officer, Chief Operating Officer

38.41K

+52.79%

Mr. Bruce D. Perkins

Independent Director

20.73K

-7.49%

Ms. Julie D. Klapstein

Lead Independent Director

12.66K

-11.70%

Mr. Nick Muscato

Chief Strategy Officer

7.02K

+229.53%

Dr. Jeffrey A. Rideout, M.D.

Independent Director

5.97K

-21.95%

Ms. Ivanetta Davis Samuels

Independent Director

4.23K

-28.39%

Revenue Breakdown

No Data

No Data

By Business

By Region

No Data

Shareholder

Update time: Sun, Feb 23

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.78%

BlackRock Institutional Trust Company, N.A.

8.36%

Fidelity Investments Canada ULC

3.81%

Pentwater Capital Management LP

3.60%

State Street Global Advisors (US)

3.03%

Other

71.43%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.78%

BlackRock Institutional Trust Company, N.A.

8.36%

Fidelity Investments Canada ULC

3.81%

Pentwater Capital Management LP

3.60%

State Street Global Advisors (US)

3.03%

Other

71.43%

Type

Shareholder

Proportion

Investment Advisor/Hedge Fund

38.64%

Investment Advisor

23.21%

Hedge Fund

20.93%

Sovereign Wealth Fund

2.87%

Pension Fund

2.48%

Research Firm

2.32%

Individual Investor

2.09%

Bank and Trust

1.29%

Venture Capital

0.07%

Other

6.11%

Institutional Shareholding

Update time: Mon, Feb 24

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

674

30.74M

93.68%

-7.18M

2024Q4

702

30.63M

93.37%

-7.89M

2024Q3

712

30.38M

92.77%

-9.62M

2024Q2

724

31.31M

95.64%

-8.96M

2024Q1

758

31.20M

95.51%

-10.42M

2023Q4

775

32.08M

98.19%

-8.32M

2023Q3

799

30.30M

92.84%

-9.14M

2023Q2

851

31.30M

96.00%

-8.46M

2023Q1

848

33.18M

101.94%

-5.60M

2022Q4

872

32.21M

99.05%

-5.50M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

3.21M

9.78%

+10.82K

+0.34%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

2.74M

8.36%

+127.19K

+4.86%

Dec 31, 2024

Fidelity Investments Canada ULC

1.25M

3.81%

-59.62K

-4.55%

Dec 31, 2024

Pentwater Capital Management LP

1.18M

3.6%

+105.00K

+9.77%

Dec 31, 2024

State Street Global Advisors (US)

993.76K

3.03%

+43.20K

+4.54%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

914.86K

2.79%

+525.47K

+134.95%

Dec 31, 2024

Alpine Associates Management Inc.

888.12K

2.71%

+27.40K

+3.18%

Dec 31, 2024

Citadel Advisors LLC

872.96K

2.66%

+268.66K

+44.46%

Dec 31, 2024

TIG Advisors, L.L.C.

710.41K

2.17%

+710.41K

--

Dec 31, 2024

AllianceBernstein L.P.

677.79K

2.07%

+13.59K

+2.05%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

First Trust Merger Arbitrage ETF

4.82%

AltShares Event-Driven ETF

4.36%

SPDR S&P Health Care Services ETF

2.01%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.57%

Global X US Cash Flow Kings 100 ETF

0.48%

iShares U.S. Healthcare Providers ETF

0.48%

Hartford Longevity Economy ETF

0.45%

Gotham 1000 Value ETF

0.45%

ETC 6 Meridian Low Beta Equity Strategy ETF

0.41%

Global X Aging Population ETF

0.27%

First Trust Merger Arbitrage ETF

Proportion4.82%

AltShares Event-Driven ETF

Proportion4.36%

SPDR S&P Health Care Services ETF

Proportion2.01%

iShares MSCI USA Small-Cap Min Vol Factor ETF

Proportion0.57%

Global X US Cash Flow Kings 100 ETF

Proportion0.48%

iShares U.S. Healthcare Providers ETF

Proportion0.48%

Hartford Longevity Economy ETF

Proportion0.45%

Gotham 1000 Value ETF

Proportion0.45%

ETC 6 Meridian Low Beta Equity Strategy ETF

Proportion0.41%

Global X Aging Population ETF

Proportion0.27%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

94.720USD

Amedisys Inc

94.720

Overview

Company